Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study
5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). To study the growth pattern in Chinese pediatric patients with 5αRD. Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pe...
Saved in:
Published in | Frontiers in pharmacology Vol. 10; p. 173 |
---|---|
Main Authors | , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
15.03.2019
|
Subjects | |
Online Access | Get full text |
ISSN | 1663-9812 1663-9812 |
DOI | 10.3389/fphar.2019.00173 |
Cover
Abstract | 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).
To study the growth pattern in Chinese pediatric patients with 5αRD.
Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.
In this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).
The height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (
= 3.658, 2.103,
= 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (
= 2.756,
= 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (
= -2.670,
= 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.
Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth. |
---|---|
AbstractList | 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).BACKGROUND5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).To study the growth pattern in Chinese pediatric patients with 5αRD.OBJECTIVETo study the growth pattern in Chinese pediatric patients with 5αRD.Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.SUBJECTSData were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.In this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).METHODSIn this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).The height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (t = 3.658, 2.103, P = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (t = 2.756, P = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (Z = -2.670, P = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.RESULTSThe height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (t = 3.658, 2.103, P = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (t = 2.756, P = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (Z = -2.670, P = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth.CONCLUSIONChildren with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth. Background5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).ObjectiveTo study the growth pattern in Chinese pediatric patients with 5αRD.SubjectsData were obtained from 141 patients with 5αRD (age: 0–16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017.MethodsIn this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS).ResultsThe height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old (t = 3.658, 2.103, P = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old (t = 2.756, P = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south (Z = -2.670, P = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD.ConclusionChildren with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys’ height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth. 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD). To study the growth pattern in Chinese pediatric patients with 5αRD. Data were obtained from 141 patients with 5αRD (age: 0-16 years old) who visited eight pediatric endocrine centers from January 2010 to December 2017. In this retrospective cohort study, height, weight, and other relevant data were collected from the multicenter hospital registration database. Baseline luteinizing hormone (LH), follicle stimulating hormone (FSH), testosterone (T), and dihydrotestosterone (DHT) after human chorionic gonadotropin (HCG) stimulation test were measured by enzyme enhanced chemiluminescence assay. Bone age (BA) was assessed using the Greulich-Pyle (G-P) atlas. Growth curve was constructed based on λ-median-coefficient of variation method (LMS). The height standard deviation scores (HtSDS) and weight standard deviation scores (WtSDS) in 5αRD children were in the normal range as compared to normal boys. Significantly higher HtSDS was observed in patients with 5αRD who were <1 year old ( = 3.658, 2.103, = 0.002, 0.048, respectively), and higher WtSDS in those <6 months old ( = 2.756, = 0.012). Then HtSDS and WtSDS decreased gradually and fluctuated near the median of the same age until 13 years. WtSDS in 5αRD children from northern China were significantly higher than those from the south ( = -2.670, = 0.008). The variation tendency of HtSDS in Chinese 5αRDs was consistent with the trend of stimulating T. HtSDS and stimulating T in the external masculinization score (EMS) <7 group were slightly higher than those in EMS ≥ 7 group without significant difference. Additionally, the ratio of BA over chronological age (BA/CA) was significantly <1 in children with 5αRD. Children with 5αRD had a special growth pattern that was affected by high levels of T, while DHT played a very small role in it. Their growth accelerated at age <1 year, followed by slowing growth and fluctuating height near normal median boys' height. The BA was delayed in 5αRD children. Androgen treatment, which may be considered anyway for male 5αRD patients with a micropenis, may also be beneficial for growth. |
Author | Chen, Shaoke Chen, Hui Gong, Chunxiu Wang, Xiumin Chen, Linqi Luo, Feihong Su, Zhe Yang, Yu Chen, Ruimin Wu, Di Zhao, Xiu Song, Yanning |
AuthorAffiliation | 1 Center of Endocrinology, Genetics and Metabolism, National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University , Beijing , China 3 Genetic and Metabolic Central Laboratory, Maternal and Children Health Hospital of Guangxi Zhuang Autonomous Region , Nanning , China 6 Department of Endocrinology, Jiangxi Provincial Children’s Hospital , Nanchang , China 4 Department of Endocrinology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University , Shanghai , China 5 Department of Endocrinology, Children’s Hospital of Fudan University, Fudan University , Shanghai , China 7 Department of Endocrinology, Children’s Hospital of Soochow University , Suzhou , China 2 Department of Endocrinology, Shenzhen Children’s Hospital , Shenzhen , China 8 Department of Endocrinology, Fuzhou Children’s Hospital , Fuzhou , China 9 Department of BME, Capital Medical University , Beijing , China |
AuthorAffiliation_xml | – name: 3 Genetic and Metabolic Central Laboratory, Maternal and Children Health Hospital of Guangxi Zhuang Autonomous Region , Nanning , China – name: 5 Department of Endocrinology, Children’s Hospital of Fudan University, Fudan University , Shanghai , China – name: 7 Department of Endocrinology, Children’s Hospital of Soochow University , Suzhou , China – name: 9 Department of BME, Capital Medical University , Beijing , China – name: 6 Department of Endocrinology, Jiangxi Provincial Children’s Hospital , Nanchang , China – name: 2 Department of Endocrinology, Shenzhen Children’s Hospital , Shenzhen , China – name: 1 Center of Endocrinology, Genetics and Metabolism, National Center for Children’s Health, Beijing Children’s Hospital, Capital Medical University , Beijing , China – name: 4 Department of Endocrinology, Shanghai Children’s Medical Center, Shanghai Jiao Tong University , Shanghai , China – name: 8 Department of Endocrinology, Fuzhou Children’s Hospital , Fuzhou , China |
Author_xml | – sequence: 1 givenname: Xiu surname: Zhao fullname: Zhao, Xiu – sequence: 2 givenname: Yanning surname: Song fullname: Song, Yanning – sequence: 3 givenname: Shaoke surname: Chen fullname: Chen, Shaoke – sequence: 4 givenname: Xiumin surname: Wang fullname: Wang, Xiumin – sequence: 5 givenname: Feihong surname: Luo fullname: Luo, Feihong – sequence: 6 givenname: Yu surname: Yang fullname: Yang, Yu – sequence: 7 givenname: Linqi surname: Chen fullname: Chen, Linqi – sequence: 8 givenname: Ruimin surname: Chen fullname: Chen, Ruimin – sequence: 9 givenname: Hui surname: Chen fullname: Chen, Hui – sequence: 10 givenname: Zhe surname: Su fullname: Su, Zhe – sequence: 11 givenname: Di surname: Wu fullname: Wu, Di – sequence: 12 givenname: Chunxiu surname: Gong fullname: Gong, Chunxiu |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/30930770$$D View this record in MEDLINE/PubMed |
BookMark | eNp1ks9u1DAQxi1URNuld07IRy5Z_G9jmwNStUCpVAQqRRwtx550vcomqeMU7WP1RXgmnN0WtUj4MpZn5vfZnu8YHbRdCwi9omTOudJv635l45wRqueEUMmfoSNalrzQirKDR_tDdDIMa5IX15qX4gU65ERzIiU5Quuz2P1KK_zNpgSxxaHFy1VoYYApNj5Ci3-GXLD4fVdcgh9dsjl3te0BM_wB6uACtG77Dp_iS0ixG3pwKdwC_jI2KThoMxZ_T6PfvkTPa9sMcHIfZ-jHp49Xy8_Fxdez8-XpReFEyVIhiAYuuKWMOyugLqmuvFasVsp6SqvSSk8EJ15wocBrryQAc7UgdGGtZHyGzvdc39m16WPY2Lg1nQ1md9DFa2NjvloDRjImSV1TC6QSFSi9kKKUlHIoa1BZYYbe71n9WG3AT8-JtnkCfZppw8pcd7emFExrpTLgzT0gdjcjDMlswuCgaWwL3TgYlucn8_DEpPX6sdZfkYdh5YJyX-DyNw8RauNCsil0k3RoDCVmMobZGcNMxjA7Y-RG8k_jA_u_LX8AQDa9Fw |
CitedBy_id | crossref_primary_10_1002_ped4_12302 crossref_primary_10_3390_jpm12050771 crossref_primary_10_1155_2022_6025916 |
Cites_doi | 10.1249/JES.0000000000000056 10.1007/s42000-018-0013-9 10.4274/jcrpe.2782 10.1007/s12098-017-2412-3 10.3969/j.issn.1673-5501.2012.03.002 10.1152/physrev.00033.2015 10.1016/j.jsbmb.2016.05.020 10.1007/s11427-017-9100-1 10.1172/JCI116665 10.1007/s11427-017-9084-9 10.1101/gr.107524.110 10.1002/0471250953.bi1110s43 10.1210/jc.2004-1303 10.1056/NEJM197212212872508 10.1210/jc.2008-2108 10.1023/A:1005326027087 10.1038/ng.806 10.1007/s00431-004-1406-0 10.1542/peds.2006-0738 10.1159/000076279 10.1515/jpem-2008-210609 10.1046/j.1464-410x.2000.00354.x 10.1210/jc.2004-1314 10.1159/000439234 10.1002/(SICI)1096-8628(19960503)63:1<223::AID-AJMG39>3.0.CO;2-O 10.1136/adc.65.10.1166 10.1038/sj.ejhg.5201232 10.1515/jpem-2016-0048 10.1111/j.1365-2265.2007.02960.x 10.1002/ajmg.c.31560 10.1210/jc.2001-011902 10.1210/edrv-14-5-577 10.1002/sim.4780111005 10.1155/2012/964876 10.1542/peds.2014-1088 10.1002/jbmr.552 10.4274/jcrpe.2495 10.1159/000271915 10.3760/cma.j.issn.0578-1310.2010.06.005 10.1002/ped4.12010 10.1210/er.2014-1024 10.1360/N972015-01212 10.1038/gim.2015.30 10.1210/jc.2011-0298 10.1111/j.1365-2265.2005.02348.x 10.1159/000315961 10.1093/humupd/7.3.314 10.1159/000445090 10.1136/fn.87.2.F150 10.1007/s11427-017-9099-3 10.1152/ajpendo.00311.2005 10.1093/molehr/gaq072 10.1530/EJE-08-0166 |
ContentType | Journal Article |
Copyright | Copyright © 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong. 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong |
Copyright_xml | – notice: Copyright © 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong. 2019 Zhao, Song, Chen, Wang, Luo, Yang, Chen, Chen, Chen, Su, Wu and Gong |
DBID | AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.3389/fphar.2019.00173 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic PubMed |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals (WRLC) url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1663-9812 |
ExternalDocumentID | oai_doaj_org_article_72270ff1ae0b4be8957467113e6fe8d4 PMC6429988 30930770 10_3389_fphar_2019_00173 |
Genre | Journal Article |
GroupedDBID | 53G 5VS 9T4 AAFWJ AAKDD AAYXX ACGFO ACGFS ACXDI ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV CITATION DIK EMOBN GROUPED_DOAJ GX1 HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
ID | FETCH-LOGICAL-c462t-409e343a123ca4ef619bd982f88ad11b6a7d0430d4348ed9d87ee2cf4015aa723 |
IEDL.DBID | M48 |
ISSN | 1663-9812 |
IngestDate | Wed Aug 27 01:26:56 EDT 2025 Thu Aug 21 18:32:50 EDT 2025 Fri Sep 05 05:43:26 EDT 2025 Thu Jan 02 22:54:18 EST 2025 Thu Apr 24 22:58:39 EDT 2025 Tue Jul 01 03:27:16 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | 46 5α-reductase type 2 deficiency testosterone children XY DSD dihydrotestosterone height |
Language | English |
License | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c462t-409e343a123ca4ef619bd982f88ad11b6a7d0430d4348ed9d87ee2cf4015aa723 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Tieliu Shi, East China Normal University, China These authors have contributed equally to this work This article was submitted to Translational Pharmacology, a section of the journal Frontiers in Pharmacology Reviewed by: Michaël R. Laurent, University Hospitals Leuven, Belgium; Chao Xu, Shandong Qianfoshan Hospital, China; Michel Polak, Necker-Enfants Malades Hospital, France |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2019.00173 |
PMID | 30930770 |
PQID | 2201717344 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_72270ff1ae0b4be8957467113e6fe8d4 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6429988 proquest_miscellaneous_2201717344 pubmed_primary_30930770 crossref_citationtrail_10_3389_fphar_2019_00173 crossref_primary_10_3389_fphar_2019_00173 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-03-15 |
PublicationDateYYYYMMDD | 2019-03-15 |
PublicationDate_xml | – month: 03 year: 2019 text: 2019-03-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Switzerland |
PublicationPlace_xml | – name: Switzerland |
PublicationTitle | Frontiers in pharmacology |
PublicationTitleAlternate | Front Pharmacol |
PublicationYear | 2019 |
Publisher | Frontiers Media S.A |
Publisher_xml | – name: Frontiers Media S.A |
References | Shen (B37) 2016; 61 Di (B12) 2013; 8 Richter-Unruh (B36) 2004; 163 Lee (B23) 2006; 118 Ishii (B17) 2015; 84 Raveenthiran (B34) 2017; 84 Ittiwut (B19) 2017; 30 Ni (B28) 2017; 60 Yarrow (B57) 2015; 43 Kolesinska (B22) 2014; 134 Veiga-Junior (B46) 2012; 2012 Ko (B21) 2010; 73 Van der Auwera (B44) 2013; 43 Mendonca (B26) 2016; 163 Bertelloni (B4) 2016; 10 Chen (B7) 2012; 7 Perry (B32) 2008; 68 Wang (B52) 2017; 60 Wilson (B55) 1993; 14 Wang (B53) 2004; 12 Ahmed (B1) 2000; 85 Ng (B27) 1990; 65 Issa (B18) 2002; 87 Nicoletti (B29) 2005; 63 Tria (B43) 2004; 61 Choi (B8) 2008; 21 Sultan (B41) 2001; 7 Veldhuis (B48); 90 Deeb (B10) 2016; 8 Sims (B39) 2006; 290 (B33) 2010; 48 Sinnecker (B40) 1996; 63 Wu (B56) 2017; 1 Li (B24) 2009; 47 Bertelloni (B5) 2010; 4 Eren (B13) 2016; 8 McKenna (B25) 2010; 20 Silver (B38) 1999 Vanderschueren (B45) 2014; 35 Hughes (B16) 2002; 87 Jia (B20) 2017; 60 Byers (B6) 2017; 175 Almeida (B2) 2017; 97 Thigpen (B42) 1993; 92 Wilson (B54) 1972; 287 Veldhuis (B49) 2011; 96 Veldhuis (B51) 2009; 94 Avendano (B3) 2018; 17 DePristo (B11) 2011; 43 Gad (B14) 1997; 20 Han (B15) 2008; 159 Nie (B30) 2011; 17 Nishiyama (B31) 2012; 27 Veldhuis (B47); 90 Veldhuis (B50) 1997; 82 Cole (B9) 1992; 11 Richards (B35) 2015; 17 |
References_xml | – volume: 43 start-page: 222 year: 2015 ident: B57 article-title: Testosterone and adult male bone: actions independent of 5alpha-reductase and aromatase. publication-title: Exerc. Sport Sci. Rev. doi: 10.1249/JES.0000000000000056 – volume: 17 start-page: 197 year: 2018 ident: B3 article-title: 5-alpha-Reductase type 2 deficiency: is there a genotype-phenotype correlation? A review. publication-title: Hormones doi: 10.1007/s42000-018-0013-9 – volume: 8 start-page: 236 year: 2016 ident: B10 article-title: Phenotype, sex of rearing, gender re-assignment, and response to medical treatment in extended family members with a novel mutation in the SRD5A2 gene. publication-title: J. Clin. Res. Pediatr. Endocrinol. doi: 10.4274/jcrpe.2782 – volume: 84 start-page: 700 year: 2017 ident: B34 article-title: Controversies of sex re-assignment in genetic males with congenital inadequacy of the penis. publication-title: Indian Pediatr. J. doi: 10.1007/s12098-017-2412-3 – volume: 7 start-page: 167 year: 2012 ident: B7 article-title: Clinical observation of short-term oral testosterone undecanoate treatment for 46, XY DSD Chinese boys with small penis: a self-comparison study. publication-title: Clin. J. Evid. Based Pediatr. doi: 10.3969/j.issn.1673-5501.2012.03.002 – volume: 97 start-page: 135 year: 2017 ident: B2 article-title: Estrogens and androgens in skeletal physiology and pathophysiology. publication-title: Physiol. Rev. doi: 10.1152/physrev.00033.2015 – volume: 163 start-page: 206 year: 2016 ident: B26 article-title: Steroid 5alpha-reductase 2 deficiency. publication-title: J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2016.05.020 – volume: 60 start-page: 681 year: 2017 ident: B28 article-title: The challenge and promise of rare disease diagnosis in China. publication-title: Sci. China Life Sci. doi: 10.1007/s11427-017-9100-1 – volume: 92 start-page: 903 year: 1993 ident: B42 article-title: Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. publication-title: Clin. J. Invest. doi: 10.1172/JCI116665 – volume: 60 start-page: 700 year: 2017 ident: B52 article-title: AR mutations in 28 patients with androgen insensitivity syndrome (Prader grade 0-3). publication-title: Sci. China Life Sci. doi: 10.1007/s11427-017-9084-9 – volume: 20 start-page: 1297 year: 2010 ident: B25 article-title: The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. publication-title: Genome Res. doi: 10.1101/gr.107524.110 – volume: 43 start-page: 1 year: 2013 ident: B44 article-title: From FastQ data to high confidence variant calls: the genome analysis toolkit best practices pipeline. publication-title: Curr. Protoc. Bioinformatics doi: 10.1002/0471250953.bi1110s43 – volume: 90 start-page: 1613 ident: B47 article-title: Testosterone blunts feedback inhibition of growth hormone secretion by experimentally elevated insulin-like growth factor-I concentrations. publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2004-1303 – volume: 287 start-page: 1284 year: 1972 ident: B54 article-title: Recent studies on the mechanism of action of testosterone. publication-title: N. Engl. J. Med. doi: 10.1056/NEJM197212212872508 – volume: 94 start-page: 973 year: 2009 ident: B51 article-title: Aromatase and 5alpha-reductase inhibition during an exogenous testosterone clamp unveils selective sex steroid modulation of somatostatin and growth hormone secretagogue actions in healthy older men. publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2008-2108 – volume: 20 start-page: 95 year: 1997 ident: B14 article-title: 5 alpha-reductase deficiency in patients with micropenis. publication-title: Inherit. J. Metab. Dis. doi: 10.1023/A:1005326027087 – volume: 47 start-page: 487 year: 2009 ident: B24 article-title: [Height and weight standardized growth charts for Chinese children and adolescents aged 0 to 18 years]. publication-title: Zhonghua Er Ke Za Zhi – volume: 43 start-page: 491 year: 2011 ident: B11 article-title: A framework for variation discovery and genotyping using next-generation DNA sequencing data. publication-title: Nat. Genet. doi: 10.1038/ng.806 – volume: 163 start-page: 251 year: 2004 ident: B36 article-title: Short stature in children with an apparently normal male phenotype can be caused by 45,X/46,XY mosaicism and is susceptible to growth hormone treatment. publication-title: Eur. Pediatr. J. doi: 10.1007/s00431-004-1406-0 – volume: 118 start-page: e488 year: 2006 ident: B23 article-title: Consensus statement on management of intersex disorders. International consensus conference on intersex. publication-title: Pediatrics doi: 10.1542/peds.2006-0738 – volume: 61 start-page: 180 year: 2004 ident: B43 article-title: Steroid 5alpha-reductase 1 polymorphisms and testosterone/dihydrotestosterone ratio in male patients with hypospadias. publication-title: Horm. Res. doi: 10.1159/000076279 – volume: 21 start-page: 545 year: 2008 ident: B8 article-title: Molecular analysis of the AR and SRD5A2 genes in patients with 46,XY disorders of sex development. publication-title: J. Pediatr. Endocrinol. Metab. doi: 10.1515/jpem-2008-210609 – volume: 85 start-page: 120 year: 2000 ident: B1 article-title: The role of a clinical score in the assessment of ambiguous genitalia. publication-title: BJU Int. doi: 10.1046/j.1464-410x.2000.00354.x – volume: 90 start-page: 2941 ident: B48 article-title: Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations. publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2004-1314 – volume: 84 start-page: 305 year: 2015 ident: B17 article-title: Human chorionic gonadotropin stimulation test in prepubertal children with micropenis can accurately predict leydig cell function in pubertal or postpubertal adolescents. publication-title: Horm. Res. Paediatr. doi: 10.1159/000439234 – volume: 63 start-page: 223 year: 1996 ident: B40 article-title: Phenotypic classification of male pseudohermaphroditism due to steroid 5 alpha-reductase 2 deficiency. publication-title: Am. J. Med. Genet. doi: 10.1002/(SICI)1096-8628(19960503)63:1<223::AID-AJMG39>3.0.CO;2-O – volume: 65 start-page: 1166 year: 1990 ident: B27 article-title: 5 alpha-reductase deficiency without hypospadias. publication-title: Arch. Dis. Child. doi: 10.1136/adc.65.10.1166 – volume: 12 start-page: 706 year: 2004 ident: B53 article-title: Mutation analysis of five candidate genes in Chinese patients with hypospadias. publication-title: Eur. Hum, J. Genet. doi: 10.1038/sj.ejhg.5201232 – start-page: 1142 year: 1999 ident: B38 article-title: 5alpha-reductase type 2 mutations are present in some boys with isolated hypospadias. publication-title: J. Urol. – volume: 30 start-page: 19 year: 2017 ident: B19 article-title: Novel mutations of the SRD5A2 and AR genes in Thai patients with 46, XY disorders of sex development. publication-title: J. Pediatr. Endocrinol. Metab. doi: 10.1515/jpem-2016-0048 – volume: 68 start-page: 4 year: 2008 ident: B32 article-title: The role of sex steroids in controlling pubertal growth. publication-title: Clin. Endocrinol. doi: 10.1111/j.1365-2265.2007.02960.x – volume: 175 start-page: 260 year: 2017 ident: B6 article-title: Unexpected ethical dilemmas in sex assignment in 46,XY DSD due to 5-alpha reductase type 2 deficiency. publication-title: Am. J. Med. Genet. C Semin. Med. Genet. doi: 10.1002/ajmg.c.31560 – volume: 87 start-page: 5401 year: 2002 ident: B18 article-title: Human osteoblast-like cells express predominantly steroid 5alpha-reductase type 1. publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2001-011902 – volume: 14 start-page: 577 year: 1993 ident: B55 article-title: Steroid 5 alpha-reductase 2 deficiency. publication-title: Endocr. Rev. doi: 10.1210/edrv-14-5-577 – volume: 11 start-page: 1305 year: 1992 ident: B9 article-title: Smoothing reference centile curves: the LMS method and penalized likelihood. publication-title: Stat. Med. doi: 10.1002/sim.4780111005 – volume: 2012 year: 2012 ident: B46 article-title: Clinical and laboratorial features that may differentiate 46,XY DSD due to partial androgen insensitivity and 5alpha-reductase type 2 deficiency. publication-title: Int. Endocrinol. J. doi: 10.1155/2012/964876 – volume: 82 start-page: 3414 year: 1997 ident: B50 article-title: Estrogen and testosterone, but not a nonaromatizable androgen, direct network integration of the hypothalamo-somatotrope (growth hormone)-insulin-like growth factor I axis in the human: evidence from pubertal pathophysiology and sex-steroid hormone replacement∗. publication-title: J. Clin. Endocrinol. Metab. – volume: 134 start-page: e710 year: 2014 ident: B22 article-title: Changes over time in sex assignment for disorders of sex development. publication-title: Pediatrics doi: 10.1542/peds.2014-1088 – volume: 27 start-page: 273 year: 2012 ident: B31 article-title: Cortical porosity is higher in boys compared with girls at the distal radius and distal tibia during pubertal growth: an HR-pQCT study. publication-title: Bone J. Miner. Res. doi: 10.1002/jbmr.552 – volume: 8 start-page: 218 year: 2016 ident: B13 article-title: Homozygous Ala65Pro mutation with V89L polymorphism in SRD5A2 deficiency. publication-title: J. Clin. Res. Pediatr. Endocrinol. doi: 10.4274/jcrpe.2495 – volume: 73 start-page: 41 year: 2010 ident: B21 article-title: Clinical characterization and analysis of the SRD5A2 gene in six Korean patients with 5alpha-reductase type 2 deficiency. publication-title: Horm. Res. Paediatr. doi: 10.1159/000271915 – volume: 48 start-page: 418 year: 2010 ident: B33 article-title: Testis volume.pubic hair development and spernmrcheal age in urban Chinese boys. publication-title: Chinese J. Pediatr. doi: 10.3760/cma.j.issn.0578-1310.2010.06.005 – volume: 1 start-page: 16 year: 2017 ident: B56 article-title: Physical assessment and reference growth curves for children with 46,XY disorders of sex development. publication-title: Pediatr. Invest. doi: 10.1002/ped4.12010 – volume: 35 start-page: 906 year: 2014 ident: B45 article-title: Sex steroid actions in male bone. publication-title: Endocr. Rev. doi: 10.1210/er.2014-1024 – volume: 61 start-page: 1733 year: 2016 ident: B37 article-title: What are the biological roots of sexual orientation? publication-title: Chin. Sci. Bull. doi: 10.1360/N972015-01212 – volume: 17 start-page: 405 year: 2015 ident: B35 article-title: Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. publication-title: Genet. Med. doi: 10.1038/gim.2015.30 – volume: 96 start-page: 2540 year: 2011 ident: B49 article-title: Gender, sex-steroid, and secretagogue-selective recovery from growth hormone-induced feedback in older women and men. publication-title: J. Clin. Endocrinol. Metab. doi: 10.1210/jc.2011-0298 – volume: 63 start-page: 375 year: 2005 ident: B29 article-title: SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. publication-title: Clin. Endocrinol. doi: 10.1111/j.1365-2265.2005.02348.x – volume: 4 start-page: 270 year: 2010 ident: B5 article-title: Bone health in disorders of sex differentiation. publication-title: Sex. Dev. doi: 10.1159/000315961 – volume: 7 start-page: 314 year: 2001 ident: B41 article-title: Disorders linked to insufficient androgen action in male children. publication-title: Hum. Reprod. Update doi: 10.1093/humupd/7.3.314 – volume: 10 start-page: 28 year: 2016 ident: B4 article-title: 5alpha-reductase-2 deficiency: clinical findings, endocrine pitfalls, and genetic features in a large italian cohort. publication-title: Sex. Dev. doi: 10.1159/000445090 – volume: 87 start-page: F150 year: 2002 ident: B16 article-title: Reduced birth weight in boys with hypospadias: an index of androgen dysfunction? publication-title: Arch. Dis. Child Fetal Neonatal Ed. doi: 10.1136/fn.87.2.F150 – volume: 60 start-page: 686 year: 2017 ident: B20 article-title: Towards efficiency in rare disease research: what is distinctive and important? publication-title: Sci. China Life Sci. doi: 10.1007/s11427-017-9099-3 – volume: 290 start-page: E456 year: 2006 ident: B39 article-title: Perinatal testosterone surge is required for normal adult bone size but not for normal bone remodeling. publication-title: Am. J. Physiol. Endocrinol. Metab. doi: 10.1152/ajpendo.00311.2005 – volume: 8 start-page: 46 year: 2013 ident: B12 article-title: Analysis of the clinical characteristics and body height in 153 disorders of sex development children without known cause. publication-title: Chin. J. Evid. Based Pediatr. – volume: 17 start-page: 57 year: 2011 ident: B30 article-title: Five novel mutations of SRD5A2 found in eight Chinese patients with 46,XY disorders of sex development. publication-title: Mol. Hum. Reprod. doi: 10.1093/molehr/gaq072 – volume: 159 start-page: 179 year: 2008 ident: B15 article-title: Comparison of bone mineral density and body proportions between women with complete androgen insensitivity syndrome and women with gonadal dysgenesis. publication-title: Eur. Endocrinol, J. doi: 10.1530/EJE-08-0166 |
SSID | ssj0000399364 |
Score | 2.2282948 |
Snippet | 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development (DSD).
To study the... 5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development... Background5α-reductase type 2 deficiency (5αRD) is an autosomal recessive hereditary disease of the group of 46, XY disorders of sex development... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 173 |
SubjectTerms | 5α-reductase type 2 deficiency dihydrotestosterone height Pharmacology testosterone XY DSD |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ3NatwwEIBFyamXkv6k2bYpKpRAIWZt_Vhyb2naJARalpDQ3IRsj9gtxRt2ncM-Vl8kz9QZ2bvZLSG59GrL9qAZe2YszTeMfUxDCJn1IalsrRNVpirxRueJDXkopEenGOh_x_cf-emlOrvSV2utvmhPWIcH7iZuaIQweMPMQ1qqEmyhqUFGlknIA9g6kkDTIl1LpuI3mPxurrp1SczCimG4Hnvif2aRT2nkhh-KuP77Ysx_t0qu-Z7jbfasDxr5YSfsc_YEmhdsf9RRpxcH_OKuiGp-wPf56I5HvXjJfp1gqt2O-SiiNBs-aTh1zYY58KO-lJv_nOAAffsnOSeUa4uujVOGygX_CsSYoALNz_yQn0M7my6rM3ms3iWZYcZpQ-LiFbs8_nZxdJr0LRaSSuWixeyxAKmkR_9VeQUB06myLqwI1vo6y8rcm5qoYLWSykJd1NYAiCpgVqa9N0LusK1m2sAu41ZbifoB61FRMvU-FMKj4krtFVHxBmy4nHBX9fxxaoPx22EeQipyUUWOVOSiigbs0-qK64698cDYL6TD1TiiZscDaEuutyX3mC0N2IelBTh8y2jpxDcwvZk7IYgrZKTCMa87i1g9itaSU2PSATMbtrIhy-aZZjKOJO-cogFr3_wP4d-ypzQdtD8u0-_YVju7gT0MmNryfXw3_gIsKhZE priority: 102 providerName: Directory of Open Access Journals |
Title | Growth Pattern in Chinese Children With 5α-Reductase Type 2 Deficiency: A Retrospective Multicenter Study |
URI | https://www.ncbi.nlm.nih.gov/pubmed/30930770 https://www.proquest.com/docview/2201717344 https://pubmed.ncbi.nlm.nih.gov/PMC6429988 https://doaj.org/article/72270ff1ae0b4be8957467113e6fe8d4 |
Volume | 10 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1fa9RAEF-0vvgi_ve0lhWkIDQ22exmN4JIrdYiKEfpYd-WTTLbOym5NpeC97H8In4mZza5O08On3xNdsmwM5OZ2Zn5DWMvY-99YpyPSlOpSBaxjJxWWWR85vPUoVH0dN_x5Wt2PJKfz9TZqj26P8DZxtCO5kmNmovXP67m71Dh31LEifZ231-OHUF7JgF6Uqc32a2QLaJCvt7ZD_9lssWZ7HKVGzeu2aYA4b_J7_y7fPIPe3R0l93pHUl-0HH-HrsB9X22O-yQqOd7_HTVWDXb47t8uMKonj9g3z9h-N2O-TDAa9Z8UnOapA0z4Id9ezf_NsEF6tfP6ITgXVs0d5yiVi74ByDcCWrafMMP-Am0zXTRsclDRy_RDA2nIsX5QzY6-nh6eBz1YxeiUmaixYgyh1SmDm1a6SR4DLGKKjfCG-OqJCkypytCCqtkKg1UeWU0gCg9RmrKOS3SR2yrntbwhHGjTFqAAePiAnc453PhUDgK5SQh5Q3Y_uLAbdljktNojAuLsQmxyAYWWWKRDSwasFfLHZcdHsc_1r4nHi7XEZJ2eDBtzm2vmFYLoVFgEwdIItKaKxrAkiQpZB5MhSS-WEiARc2jdIqrYXo9s0IQ1pBOJa553EnE8lOUX461jgdMr8nKGi3rb-rJOKB7Z-QhGPP0fxD_jN2m46CauURts622uYbn6ES1xU64fNgJGvIbalAfbg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Growth+Pattern+in+Chinese+Children+With+5%CE%B1-Reductase+Type+2+Deficiency%3A+A+Retrospective+Multicenter+Study&rft.jtitle=Frontiers+in+pharmacology&rft.au=Xiu+Zhao&rft.au=Xiu+Zhao&rft.au=Yanning+Song&rft.au=Shaoke+Chen&rft.date=2019-03-15&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=10&rft_id=info:doi/10.3389%2Ffphar.2019.00173&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_72270ff1ae0b4be8957467113e6fe8d4 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |